These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6654972)

  • 1. PISA--a noninvasive method in the evaluation of protective effect of methylprednisolone on the ischemic myocardium.
    Prasad K; Gupta MM; Yu J
    J Cardiovasc Surg (Torino); 1983; 24(6):610-21. PubMed ID: 6654972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PISA: a noninvasive method in detection and quantification of acid-induced myocardial infarction in dogs.
    Prasad K; Gupta MM
    Clin Cardiol; 1981; 4(4):180-7. PubMed ID: 7273501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PISA--a new noninvasive method for early detection and quantification of ischemia in hypertensive patients.
    Prasad K; Gupta MM; Nikiforuk PN; Ezenwa BN; Ito K; Sterns C; Rebenal P; Singh BN; Shah PM
    Angiology; 1985 Feb; 36(2):75-87. PubMed ID: 4025924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization.
    Skyschally A; Haude M; Dörge H; Thielmann M; Duschin A; van de Sand A; Konietzka I; Büchert A; Aker S; Massoudy P; Schulz R; Erbel R; Heusch G
    Circulation; 2004 May; 109(19):2337-42. PubMed ID: 15117838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the effects of glucagon on ouabain-induced cardiac disorders using the PISA method.
    Gupta MM; Prasad K
    Adv Myocardiol; 1980; 1():313-9. PubMed ID: 7394336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal changes in an animal model of myocardial ischemia. Treatment with methylprednisolone.
    Weglicki WB; Kennett FF; Ruth RC
    Adv Myocardiol; 1980; 2():371-81. PubMed ID: 7423051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of methylprednisolone on the heart during ischemic arrest.
    Busuttil RW; George WJ; Hewitt RL
    J Thorac Cardiovasc Surg; 1975 Dec; 70(6):955-65. PubMed ID: 171523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs.
    Heng MK; Singh BN; Norris RM; John MB; Elliot R
    J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of megadose methylprednisolone on experimental myocardial infarct size.
    Shatney CH; Lillehei RC
    Adv Shock Res; 1982; 8():187-93. PubMed ID: 7136944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone reduces acute ischemic injury of the myocardium.
    Feola M; Crass MF
    Surg Gynecol Obstet; 1986 Dec; 163(6):523-30. PubMed ID: 3787426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection with methylprednisolone. Evaluation of viability of hearts subjected to warm ischemia before transplantation.
    Toledo-Pereyra LH; Jara FM
    J Thorac Cardiovasc Surg; 1979 Apr; 77(4):619-21. PubMed ID: 370461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of myocardial revascularization on acute phase of myocardial infacrtion. Macroscopic, histological and electrocardiographic data.
    Kawamura M; Sakakibara B; Sakakibara K; Uno Y
    J Cardiovasc Surg (Torino); 1976; 17(2):162-9. PubMed ID: 1262386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylprednisolone on coronary blood flow and myocardial metabolism during cardiopulmonary bypass.
    Vinas JF; Fewel JG; Grover FL; Richardson JD; Arom KV; Webb GE; Trinkle JK
    Surgery; 1977 Jun; 81(6):646-52. PubMed ID: 860199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal factors in the reduction of myocardial infarct volume by methylprednisolone.
    Shatney CH; MacCarter DJ; Lillehei RC
    Surgery; 1976 Jul; 80(1):61-9. PubMed ID: 1273768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a lymphagogue, CLS 2210, on regional cardiac lymphatics and the electrocardiogram after coronary artery occlusion in the dog.
    Szlavy L; Repa I; De Courten A
    Lymphology; 1986 Mar; 19(1):15-20. PubMed ID: 3755203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of experimental myocardial infarct size by combined treatment with methylprednisolone sodium succinate and betahistine hydrochloride.
    Joyce LD; Smith JM; Mauer HG; Lillehei RC
    Adv Shock Res; 1978; 1():235-49. PubMed ID: 400421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PISA--a new noninvasive method for early detection and quantification of heart disease.
    Prasad K; Gupta MM
    Adv Myocardiol; 1980; 1():287-312. PubMed ID: 7394335
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of methylprednisolone on cardiac lymph in acute myocardial ischemia in dogs.
    Ali M; Ellis A; Glick G
    Am J Physiol; 1977 Jun; 232(6):H602-7. PubMed ID: 879299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.